Navigating Targeted Therapy Access: Innovations...

By João L. Carapinha

November 14, 2025

Evolving Landscape of Targeted Therapies and Access Challenges Expanding targeted therapy access remains a critical challenge amid the pharmaceutical market's shift towa...
Weight Loss: Advances in Hormone-Based Obesity Treatments
NICE NHS Prioritization: A Strategic Shift to Address Healthcare Challenges
Koselugo EU Approval: A Milestone in Treating Plexiform Neurofibromas for Adu...
Barriers to African Pharmaceutical Growth: Navigating Regulatory and Procurem...
Challenging the Narrative: Pharmaceutical Innovation Funding and Its Complex ...
NICE Endorses Darolutamide Prostate Cancer Treatment for Improved Patient Access
Rethinking Health Technology Assessment: Evolving Economic Evaluations for Fa...
Cabotegravir HIV Prevention: First Injectable PrEP Recommended for High-Risk ...
Datroway TNBC Therapy: Transforming First-Line Treatment for Metastatic Tripl...
Paving the Way for Digital Health Technologies: NICE’s Bold New Strateg...
Lurbinectedin SCLC Therapy: FDA Approval and Its Economic Implications
Pfizer Trump Drug Prices: A Landmark Deal for Affordable Medications